Atrys Health, S.A. (A2T.F)

2,9100 +0,1900 (+6,99%) Börsenschluss: 03:29PM CEST

Atrys Health, S.A.

Calle VelAzquez, 24
4th Floor Right
Madrid 28001
Spain

https://www.atryshealth.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 1.669

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Santiago De Torres Sanahuja	Executive Chairman	N/A	N/A	N/A
Ms. Isabel Lozano Fernandez	CEO & Executive Director	N/A	N/A	N/A
Dr. Carlos Cordon-Cardo	Founder & Scientific Vice President	N/A	N/A	N/A
Dr. Zvi Fuchs	Founder and Medical Vice President	N/A	N/A	N/A
Mr. Jose Maria Huch Ginesta	Chief Financial Officer	N/A	N/A	N/A
Luis Duran	Global Chief Technology Officer	N/A	N/A	N/A
Encarna Vega	Administration Director	N/A	N/A	N/A
Ms. Maria Marin	Head of Investor Relations	N/A	N/A	N/A
Ms. Gabriela Camunas	General Counsel	N/A	N/A	N/A
Pedro Salord	People Director	N/A	N/A	N/A

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. The company was incorporated in 2007 and is headquartered in Madrid, Spain.

Corporate Governance

Atrys Health, S.A.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.